📰 Athersys Inc News
Page 9 - Athersys Inc News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Athersys Inc. Real-time updates on events, politics, business and more.
July 3, 2023
Gainers Micromobility.com Inc. (NASDAQ: MCOM) shares surged 60% to $0.18 in pre-market trading. micromobility.com recently reported a strategic realignment to strengthen its financial position and drive profitability.
June 26, 2023
In this article, we will be taking a look at the 25 states with the highest life expectancy in the U.S. To skip our detailed analysis, you can go directly to see the 5 states with the highest life expectancy in the U.S. According to Peterson-KFF, the average life expectancy in the U.S. in 2021 […]
June 26, 2023
In this article, we will be taking a look at the 25 states with the highest life expectancy in the U.S.
June 2, 2023
CLEVELAND--(BUSINESS WIRE)--Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem® (invimestrocel) cell therapy for critical care indications, announces patient enrollment has begun in the third and final cohort in MATRICS-1, the Phase 2 clinical study evaluating MultiStem® in patients...
June 1, 2023
Athersys, Inc. , a regenerative medicine company developing MultiStem® cell therapy for critical care indications, announces patient enrollment has begun in the third and final cohort in... | June 1, 2023
June 1, 2023
01.06.2023 - Athersys, Inc. (NASDAQ: ATHX), a regenerative medicine company developing MultiStem (invimestrocel) cell therapy for critical care indications, announces patient enrollment has begun in the third and final cohort in MATRICS-1, the Phase 2 clinical ... Seite 1
June 1, 2023
FinancialContent fully hosted finance channel
May 23, 2023
The Cleveland-based regenerative medicine company announced it has restructured its outstanding debt with a supplier that assists in the manufacturing of the MultiStem product. The deal helps advance a financial restructuring that Athersys started last year.
May 21, 2023
StockNews.com upgraded shares of Athersys (NASDAQ:ATHX – Get Rating) from a sell rating to a hold rating in a report released on Saturday morning. Separately, Alliance Global Partners assumed coverage on shares of Athersys in a report on Monday, March 6th. They set a buy rating and a $5.50 price objective for the company. Athersys […]
May 18, 2023
Athersys, Inc. , a regenerative medicine company developing MultiStem® cell therapy for critical care indications, announced on Monday, May 15th financial results for the three months ended... | May 18, 2023